Interestingly, it has been shown that increased levels of BDNF mRNA in the temporal cortex of patients with pharmacoresistant epilepsy, and the expression of GR was also influenced in the same direction [94], implying a converging behavior of BDNF and GR levels in the CNS of some neurological disorders. This evidence concerns the gene BDNF and nervous system disorder.